Sign In
Buy ALLK
$0.329
+0 (+0%)
At Close: Aug 14, 2025
2020 Chronic Inducible Urticaria Market Insights, Epidemiology, and Global Market Forecast to 2030 - ResearchAndMarkets.com
12:00am, Thursday, 06'th Aug 2020
The
Walmart’s Myntra goes international; enters Middle East with around half a dozen in-house brands
06:21pm, Wednesday, 29'th Jul 2020
Dressberry, Mast & Harbour, Moda Rapido, Here & Now, Sztori, and HRX are the brands launched on Noon. Among them, Dressberry, Mast & Harbour, and HRX will be sold on Namshi too apart from Wrogn over t
Companies Like Allakos (NASDAQ:ALLK) Can Afford To Invest In Growth
01:55pm, Saturday, 18'th Jul 2020
We can readily understand why investors are attracted to unprofitable companies. For example, Allakos (NASDAQ:ALLK...
Allakos Inc (NASDAQ:ALLK) Stock Position Lifted by Royal Bank of Canada
08:14am, Friday, 17'th Jul 2020
Royal Bank of Canada boosted its stake in shares of Allakos Inc (NASDAQ:ALLK) by 192.7% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned
Allakos (NASDAQ:ALLK) Downgraded to Sell at Zacks Investment Research
05:26am, Tuesday, 14'th Jul 2020
Zacks Investment Research downgraded shares of Allakos (NASDAQ:ALLK) from a hold rating to a sell rating in a research report sent to investors on Monday morning, Zacks.com reports. According to Zacks
Hedge Funds Dropped The Ball On Allakos Inc. (ALLK)
07:31pm, Sunday, 05'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
Two Sigma Investments LP Purchases Shares of 32,984 Allakos Inc (NASDAQ:ALLK)
08:32am, Monday, 22'nd Jun 2020
Two Sigma Investments LP purchased a new stake in Allakos Inc (NASDAQ:ALLK) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institut
Wellington Management Group LLP Increases Stock Position in Allakos Inc (NASDAQ:ALLK)
06:34am, Saturday, 20'th Jun 2020
Wellington Management Group LLP lifted its stake in Allakos Inc (NASDAQ:ALLK) by 124.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Comm
Alliancebernstein L.P. Boosts Position in Allakos Inc (NASDAQ:ALLK)
07:31am, Thursday, 18'th Jun 2020
Alliancebernstein L.P. boosted its holdings in Allakos Inc (NASDAQ:ALLK) by 16.4% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 377,940 shares of the com
BALA CYNWYD, PA / ACCESSWIRE / June 16, 2020 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims regarding the following companies for possible breaches of fiducia
Allakos Inc (NASDAQ:ALLK) Short Interest Update
06:36am, Sunday, 14'th Jun 2020
Allakos Inc (NASDAQ:ALLK) was the target of a significant decrease in short interest in May. As of May 29th, there was short interest totalling 6,820,000 shares, a decrease of 7.3% from the May 14th t
Allakos Inc (NASDAQ:ALLK) Shares Bought by State Street Corp
05:44am, Wednesday, 10'th Jun 2020
State Street Corp grew its holdings in shares of Allakos Inc (NASDAQ:ALLK) by 0.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 810,153 shares of
Allakos Inc (NASDAQ:ALLK) Shares Sold by Bank of New York Mellon Corp
04:24am, Wednesday, 10'th Jun 2020
Bank of New York Mellon Corp lowered its holdings in Allakos Inc (NASDAQ:ALLK) by 13.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission
Allakos Initiates Patient Recruitment for AK002 Registrational Studies
12:01pm, Wednesday, 03'rd Jun 2020
-- Phase 3 study in eosinophilic gastritis and/or eosinophilic duodenitis and Phase 2/3 study in eosinophilic esophagitis -- -- Top-line safety and efficacy results from.
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the Digital EAACI Annual Congress 2020
12:01pm, Thursday, 21'st May 2020
REDWOOD CITY, Calif., May 21, 2020 -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast.
